-transparent.png){kind=logo}
5-Azacytidine and sodium butyrate, two DNA methylation-disrupting agents, were tested for radioprotective properties on V79A03 cells. Both compounds can activate genes not previously expressed (e.g. metallothionein). 5-Azacytidine treatment (3 microM, 24 h) caused a 50% decrease in the 5-methylcytosine content of V79A03 DNA whereas sodium butyrate treatment (1 mM, 24h) resulted in a 700% increase in 5-methylcytosine content. Additionally, 5-azacytidine treatment resulted in the increased survival of V79A03 cells, with treatment 24 h prior to exposure to gamma radiation providing a dose reduction factor of 1.8. Sodium butyrate treatment did not result in a significant increase in survival. These results indicate that the hypomethylation of genomic DNA prior to exposure to gamma radiation correlates with an increase in survival of V79A03 cells, possibly due to the activation of the enzymes involved in repair.
J F Kalinich, and
G N Catravas, and
S L Snyder
November 1972,
Casopis lekaru ceskych,
J F Kalinich, and
G N Catravas, and
S L Snyder
January 1955,
Journal de radiologie, d'electrologie & archives d'electricite medicale,
J F Kalinich, and
G N Catravas, and
S L Snyder
January 1977,
Radiobiologiia,
J F Kalinich, and
G N Catravas, and
S L Snyder
January 1975,
Farmakologiia i toksikologiia,
J F Kalinich, and
G N Catravas, and
S L Snyder
October 1968,
Revue medicale de Liege,
J F Kalinich, and
G N Catravas, and
S L Snyder
November 1962,
Orvosi hetilap,
J F Kalinich, and
G N Catravas, and
S L Snyder
December 1993,
Arhiv za higijenu rada i toksikologiju,
J F Kalinich, and
G N Catravas, and
S L Snyder
January 1973,
Radiobiologiia,
J F Kalinich, and
G N Catravas, and
S L Snyder
March 1962,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
J F Kalinich, and
G N Catravas, and
S L Snyder
January 1977,
Radiobiologiia,
